Status:
RECRUITING
Lung Cancer Biomarkers and Screening
Lead Sponsor:
NYU Langone Health
Conditions:
Lung Cancer
Eligibility:
All Genders
50+ years
Brief Summary
RATIONALE: Screening tests that use biomarkers may help doctors find tumor cells early and plan effective treatment for lung cancer. PURPOSE: This clinical trial is studying biomarkers in screening p...
Detailed Description
OBJECTIVES: * Identify and validate biomarkers for the early detection of lung cancer in individuals at low- or high-risk for smoking-related cancers. * Identify preneoplastic cellular changes and le...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Screening Cohort
- At high- or low-risk for lung cancer
- Smoking history ≥ 20 pack years\*
- With or without workplace exposure to asbestos
- NOTE: \* Participants with \< 20 pack years of smoking are eligible if 50 years of age or older
- Rule-Out Lung cancer group
- Referred for evaluation of suspicious nodules with 1 of the following diagnoses:
- Lung cancer
- Nonmalignant nodules (control group)
- PATIENT CHARACTERISTICS:
- Not pregnant
- No prior malignancy except nonmelanoma skin cancer
- PRIOR CONCURRENT THERAPY:
- Not specified
Exclusion
Key Trial Info
Start Date :
May 1 2000
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2030
Estimated Enrollment :
10850 Patients enrolled
Trial Details
Trial ID
NCT00301119
Start Date
May 1 2000
End Date
May 1 2030
Last Update
June 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Cancer Institute at New York University Medical Center
New York, New York, United States, 10016